These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 38692955

  • 1. Distributions of candidate vaccine Targets, virulence Factors, and resistance features of invasive group B Streptococcus using Whole-Genome Sequencing: A Multicenter, population-based surveillance study.
    Ji W, Zhou H, Li J, Britto CD, Liu Z, Zhang W, Du J, Madhi SA, Kwatra G, Dangor Z, Jin Z, Zhao H, Zhao Y, Fang Y, Li J.
    Vaccine; 2024 Jun 11; 42(16):3564-3571. PubMed ID: 38692955
    [Abstract] [Full Text] [Related]

  • 2. Genomic insights into the diversity, virulence, and antimicrobial resistance of group B Streptococcus clinical isolates from Saudi Arabia.
    Alzayer M, Alkhulaifi MM, Alyami A, Aldosary M, Alageel A, Garaween G, Shibl A, Al-Hamad AM, Doumith M.
    Front Cell Infect Microbiol; 2024 Jun 11; 14():1377993. PubMed ID: 38711928
    [Abstract] [Full Text] [Related]

  • 3. Molecular characteristics of group B Streptococcus isolates from infants in southern mainland China.
    Li J, Ji W, Gao K, Zhou H, Zhang L, Mu X, Yuan C, Guan X, Deng Q, Zhang L, Zhong H, Gao X, Gao F, Long Y, Chang CY, McIver DJ, Liu H.
    BMC Infect Dis; 2019 Sep 18; 19(1):812. PubMed ID: 31533652
    [Abstract] [Full Text] [Related]

  • 4. Microbiological and clinical characteristics of Group B Streptococcus isolates causing materno-neonatal infections: high prevalence of CC17/PI-1 and PI-2b sublineage in neonatal infections.
    Lu B, Wu J, Chen X, Gao C, Yang J, Li Y, Wang J, Zeng J, Fang Y, Wang D, Cui Y, Wang L.
    J Med Microbiol; 2018 Nov 18; 67(11):1551-1559. PubMed ID: 30265233
    [Abstract] [Full Text] [Related]

  • 5. Prevalence, population structure, distribution of serotypes, pilus islands and resistance genes among erythromycin-resistant colonizing and invasive Streptococcus agalactiae isolates recovered from pregnant and non-pregnant women in Isfahan, Iran.
    Motallebirad T, Fazeli H, Ghahiri A, Shokri D, Jalalifar S, Moghim S, Esfahani BN.
    BMC Microbiol; 2021 May 04; 21(1):139. PubMed ID: 33947330
    [Abstract] [Full Text] [Related]

  • 6. Multistate, Population-Based Distributions of Candidate Vaccine Targets, Clonal Complexes, and Resistance Features of Invasive Group B Streptococci Within the United States, 2015-2017.
    McGee L, Chochua S, Li Z, Mathis S, Rivers J, Metcalf B, Ryan A, Alden N, Farley MM, Harrison LH, Snippes Vagnone P, Lynfield R, Smelser C, Muse A, Thomas AR, Schrag S, Beall BW.
    Clin Infect Dis; 2021 Mar 15; 72(6):1004-1013. PubMed ID: 32060499
    [Abstract] [Full Text] [Related]

  • 7. Features of Streptococcus agalactiae strains recovered from pregnant women and newborns attending different hospitals in Ethiopia.
    Ali MM, Woldeamanuel Y, Asrat D, Fenta DA, Beall B, Schrag S, McGee L.
    BMC Infect Dis; 2020 Nov 16; 20(1):848. PubMed ID: 33198686
    [Abstract] [Full Text] [Related]

  • 8. Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.
    Meehan M, Cunney R, Cafferkey M.
    Eur J Clin Microbiol Infect Dis; 2014 Jul 16; 33(7):1155-62. PubMed ID: 24469423
    [Abstract] [Full Text] [Related]

  • 9. Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland.
    Sadowy E, Matynia B, Hryniewicz W.
    J Antimicrob Chemother; 2010 Sep 16; 65(9):1907-14. PubMed ID: 20584746
    [Abstract] [Full Text] [Related]

  • 10. Serotype Distribution, Virulence Determinants and Antimicrobial Susceptibility of Streptococcus agalactiae Isolated from Young Infants.
    Jin Z, Li J, Zhou H, Wang Z, Yi L, Liu N, Du J, Chang CY, Ji W.
    Pathogens; 2022 Nov 15; 11(11):. PubMed ID: 36422606
    [Abstract] [Full Text] [Related]

  • 11. Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.
    Bergal A, Loucif L, Benouareth DE, Bentorki AA, Abat C, Rolain JM.
    Eur J Clin Microbiol Infect Dis; 2015 Dec 15; 34(12):2339-48. PubMed ID: 26415872
    [Abstract] [Full Text] [Related]

  • 12. Unveiling the genetic landscape of Streptococcus agalactiae bacteremia: emergence of hypervirulent CC1 strains and new CC283 strains in Tehran, Iran.
    Mohammadi A, Amini C, Bagheri P, Salehi Z, Goudarzi M.
    BMC Microbiol; 2024 Sep 28; 24(1):365. PubMed ID: 39342084
    [Abstract] [Full Text] [Related]

  • 13. Molecular characteristics and antimicrobial resistance in invasive and noninvasive Group B Streptococcus between 2008 and 2015 in China.
    Lu B, Chen X, Wang J, Wang D, Zeng J, Li Y, Li D, Zhu F, Cui Y, Huang L.
    Diagn Microbiol Infect Dis; 2016 Dec 28; 86(4):351-357. PubMed ID: 27692802
    [Abstract] [Full Text] [Related]

  • 14. Genomic characterization and resistance features of Streptococcus agalactiae isolated from non-pregnant adults in Shandong, China.
    Gong X, Jin Y, Han X, Jiang X, Miao B, Meng S, Zhang J, Zhou H, Zheng H, Feng J, Li J.
    J Glob Antimicrob Resist; 2024 Sep 28; 38():146-153. PubMed ID: 38866137
    [Abstract] [Full Text] [Related]

  • 15. Molecular characteristics of Streptococcus agalactiae in a mother-baby prospective cohort study: Implication for vaccine development and insights into vertical transmission.
    Li S, Wen G, Cao X, Guo D, Yao Z, Wu C, Ye X.
    Vaccine; 2018 Apr 05; 36(15):1941-1948. PubMed ID: 29519594
    [Abstract] [Full Text] [Related]

  • 16. Genomic and phenotypic characterisation of invasive neonatal and colonising group B Streptococcus isolates from Slovenia, 2001-2018.
    Perme T, Golparian D, Bombek Ihan M, Rojnik A, Lučovnik M, Kornhauser Cerar L, Fister P, Lozar Krivec J, Grosek Š, Ihan A, Jeverica S, Unemo M.
    BMC Infect Dis; 2020 Dec 16; 20(1):958. PubMed ID: 33327946
    [Abstract] [Full Text] [Related]

  • 17. Genomic epidemiology of group B streptococci spanning 10 years in an Irish maternity hospital, 2008-2017.
    Meehan M, Eogan M, McCallion N, Cunney R, Bray JE, Jolley KA, Unitt A, Maiden MCJ, Harrison OB, Drew RJ.
    J Infect; 2021 Jul 16; 83(1):37-45. PubMed ID: 33862060
    [Abstract] [Full Text] [Related]

  • 18. Molecular Characteristics of IS1216 Carrying Multidrug Resistance Gene Cluster in Serotype III/Sequence Type 19 Group B Streptococcus.
    Zhi Y, Ji HJ, Jung JH, Byun EB, Kim WS, Lin SM, Lim S, Jang AY, Choi MJ, Ahn KB, Lim JH, Song JY, Seo HS.
    mSphere; 2021 Aug 25; 6(4):e0054321. PubMed ID: 34319128
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing Streptococcus agalactiae (group B streptococcus) from Malaysian patients.
    Eskandarian N, Ismail Z, Neela V, van Belkum A, Desa MN, Amin Nordin S.
    Eur J Clin Microbiol Infect Dis; 2015 Mar 25; 34(3):579-84. PubMed ID: 25359580
    [Abstract] [Full Text] [Related]

  • 20. Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants.
    Otaguiri ES, Morguette AE, Tavares ER, dos Santos PM, Morey AT, Cardoso JD, Perugini MR, Yamauchi LM, Yamada-Ogatta SF.
    BMC Microbiol; 2013 Dec 21; 13():297. PubMed ID: 24359590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.